PHR Phreesia Forecast, Technical & Fundamental Analysis
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes... Show more
PHR is expected to report earnings to rise 73.80% to 8 cents per share on September 09
Q3'26
Est.
$0.09
Q2'26
Beat
by $0.04
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.07
Q3'25
Beat
by $0.07
The last earnings report on May 27 showed earnings per share of 5 cents, beating the estimate of 0 cents. With 77.68K shares outstanding, the current market capitalization sits at 676.22M.
A.I. Advisor
published General Information
General Information
a provider of patient check-in solutions for medical practices
A.I.dvisor indicates that over the last year, PHR has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PHR jumps, then COIN could also see price increases.
Momentum Indicator for PHR turns positive, indicating new upward trend
PHR saw its Momentum Indicator move above the 0 level on June 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for PHR just turned positive on June 26, 2026. Looking at past instances where PHR's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
PHR moved above its 50-day moving average on June 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PHR crossed bullishly above the 50-day moving average on June 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PHR advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PHR broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.535) is normal, around the industry mean (7.366). P/E Ratio (55.750) is within average values for comparable stocks, (50.081). PHR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.153). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (1.121) is also within normal values, averaging (5.651).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.
